Overview
What It Is Medtronic’s adaptive (closed-loop) deep-brain stimulation systems sense brain signals in real time and automatically adjust stimulation parameters. In Parkinson’s disease this allows the device to respond to fluctuating symptoms rather than delivering continuous fixed stimulation.
How It Works Continuous DBS can help but may over- or under-stimulate as symptoms change. Adaptive systems measure neural markers and adjust stimulation accordingly, aiming for more stable control with fewer side effects. Over time, more precise stimulation may also support healthier network dynamics.
Conditions - Primary use: Parkinson’s disease (adaptive features building on established DBS indications). - Note: Surgical and stimulation-related risks apply (speech, mood, balance changes). Coverage generally follows standard DBS rules when criteria are met.
How it is administered
Surgical implantation of electrodes and a sensing-capable pulse generator, followed by programming and ongoing adjustment. Adaptive algorithms respond to real-time brain signals.
Conditions connected in the NPA database
The NPA Treatment Database lists this treatment in connection with 1 condition record. A database relationship does not establish effectiveness, safety, or suitability for an individual.
Related questions
These controlled question pages reference this treatment through stored condition relationships.
Symptoms connected in the NPA database
The current record associates this treatment with the following symptom information. This is not a claim that the treatment will improve these symptoms.
Motor Control
- balance and gait problems
- rigidity/stiffness
- slowed movement (bradykinesia)
- Tremor
Sensory & Pain
- Pain
- reduced sense of smell
- sensory changes
Practical information
Insurance coverage
Covered similarly to standard Deep Brain Stimulation for eligible Parkinson’s patients when criteria met.
Cost information
High (implantable device + surgery + programming; tens of thousands before insurance).
Results and outcomes described in the source record
Symptom control begins after programming; adaptive benefits assessed over weeks to months.
Side effects and risks
Surgical risks plus standard DBS side effects (speech, mood, balance changes possible).
Research context in the NPA database
This section reproduces the current database's research summary and detail. Structured citation metadata has not been supplied, so it should not be read as an independently verified literature review.
Research summary
Evidence Level: Moderate to Strong (for Parkinson’s)
What the research shows: Trials support adaptive (closed-loop) deep brain stimulation as a safe and effective way to adjust stimulation based on real-time brain signals in Parkinson’s disease.
Key takeaway: An advanced form of deep brain stimulation that can respond to changing symptoms rather than delivering constant stimulation.
Research detail
Overview Medtronic’s adaptive (or closed-loop) deep-brain stimulation systems sense brain signals in real time and automatically adjust stimulation parameters. In Parkinson’s disease this allows the device to respond to fluctuating symptoms rather than delivering continuous fixed stimulation. The system requires surgical implantation of electrodes and a sensing-capable pulse generator, followed by programming and ongoing management. Adaptive algorithms aim to improve symptom control while reducing energy use and side effects.
Evidence Base and Published Work • The ADAPT-PD trial and related studies support the safety and performance of adaptive DBS for Parkinson’s. • Adaptive algorithms adjust stimulation based on real-time brain signals. • Key published work includes: – ADAPT-PD and related trials supporting safety and performance of adaptive DBS in Parkinson’s. – Reviews of adaptive/closed-loop DBS technologies. – Coverage is generally similar to that of conventional DBS when patients meet established criteria. Surgical and stimulation-related risks (speech, mood, balance changes) apply. Evidence is moderate-to-strong for Parkinson’s.
Outcomes Outcomes most frequently described include improved symptom control that can respond to changing symptoms rather than delivering constant stimulation. Evidence is moderate-to-strong for Parkinson’s disease.
Questions to ask a provider
1. Am I a candidate for adaptive (closed-loop) DBS versus conventional continuous DBS for my Parkinson’s? 2. What additional surgical or programming considerations come with a sensing-capable system? 3. What benefits in symptom control or side-effect reduction have been seen with adaptive algorithms? 4. How will the device be programmed and adjusted over time? 5. Is the adaptive system covered by insurance in the same way as standard DBS for my indication?
Website and contact information
Explore the interactive Treatment Database
Continue to compare educational treatment information in the interactive database. The standard disclaimer acknowledgement is required before the database opens.
Explore treatment information in the database